IS INCREASED HCV CASE-FINDING COMBINED WITH CURRENT OR 8–12 WEEK DAA THERAPY COST-EFFECTIVE IN UK PRISONS? A PREVENTION BENEFIT ANALYSIS

類似資料

• The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention
  著者:: Martin, Natasha K., 等
  出版事項: (2015)
• Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
  著者:: Martin, Natasha K, 等
  出版事項: (2013)
• HCV Treatment as Prevention in People Who Inject Drugs – testing the evidence
  著者:: Hickman, Matthew, 等
  出版事項: (2015)
• Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
  著者:: Stone, Jack, 等
  出版事項: (2017)
• Chronic hepatitis B virus case-finding in UK populations born abroad in intermediate or high endemicity countries: an economic evaluation
  著者:: Martin, Natasha K, 等
  出版事項: (2019)